Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

100 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
How has the OSD affected our state hospitals?
Parkes J, Abratt R, Taylor A, le Feuvre D, Murray E, Robertson B, Kotze T, Marais D, Khan D, Kilborn T, Wieselthaler N, Gajjar H, Handler L, Fagan J, Spitaels A, Morrison A, Davidson A, Salie S, Urban M, Rajkumar A, Pretorius V, van Niekerk M, Ferreira G, Wolmerans M, Cyster L, King D, Okwuosa S, van Staden S, van Niekerk M, Winckler J, Meissenheimer H, Botes A, Tait D, Visagie J, Swarts S, Klocke M, Lomas V, Marais I, Vijoen W, Perry J, Nkosi N, Stuve K. Parkes J, et al. Among authors: winckler j. S Afr Med J. 2009 Nov;99(11):788-9. S Afr Med J. 2009. PMID: 20218474 No abstract available.
Pharmacokinetics and Safety of Bedaquiline in Human Immunodeficiency Virus (HIV)-Positive and Negative Older Children and Adolescents With Rifampicin-Resistant Tuberculosis.
Hughes JA, Solans BP, Draper HR, Schaaf HS, Winckler JL, van der Laan L, Radtke KK, Fourie B, Wiesner L, Hesseling AC, Savic RM, Garcia-Prats AJ. Hughes JA, et al. Among authors: winckler jl. Clin Infect Dis. 2022 Nov 14;75(10):1772-1780. doi: 10.1093/cid/ciac252. Clin Infect Dis. 2022. PMID: 35377434 Free PMC article.
Pharmacokinetics and Dose Optimization Strategies of Para-Aminosalicylic Acid in Children with Rifampicin-Resistant Tuberculosis.
van der Laan LE, Garcia-Prats AJ, Schaaf HS, Chirehwa M, Winckler JL, Mao J, Draper HR, Wiesner L, Norman J, McIlleron H, Donald PR, Hesseling AC, Denti P. van der Laan LE, et al. Among authors: winckler jl. Antimicrob Agents Chemother. 2022 Jun 21;66(6):e0226421. doi: 10.1128/aac.02264-21. Epub 2022 May 4. Antimicrob Agents Chemother. 2022. PMID: 35506699 Free PMC article.
Pharmacokinetics and Drug-Drug Interactions of Abacavir and Lamuvudine Co-administered With Antituberculosis Drugs in HIV-Positive Children Treated for Multidrug-Resistant Tuberculosis.
van der Laan LE, Garcia-Prats AJ, Schaaf HS, Winckler JL, Draper H, Norman J, Wiesner L, McIlleron H, Denti P, Hesseling AC. van der Laan LE, et al. Among authors: winckler jl. Front Pharmacol. 2021 Oct 8;12:722204. doi: 10.3389/fphar.2021.722204. eCollection 2021. Front Pharmacol. 2021. PMID: 34690765 Free PMC article.
Pharmacokinetics and Drug-Drug Interactions of Lopinavir-Ritonavir Administered with First- and Second-Line Antituberculosis Drugs in HIV-Infected Children Treated for Multidrug-Resistant Tuberculosis.
van der Laan LE, Garcia-Prats AJ, Schaaf HS, Tikiso T, Wiesner L, de Kock M, Winckler J, Norman J, McIlleron H, Denti P, Hesseling AC. van der Laan LE, et al. Among authors: winckler j. Antimicrob Agents Chemother. 2018 Jan 25;62(2):e00420-17. doi: 10.1128/AAC.00420-17. Print 2018 Feb. Antimicrob Agents Chemother. 2018. PMID: 29133558 Free PMC article.
Pharmacokinetics, optimal dosing, and safety of linezolid in children with multidrug-resistant tuberculosis: Combined data from two prospective observational studies.
Garcia-Prats AJ, Schaaf HS, Draper HR, Garcia-Cremades M, Winckler J, Wiesner L, Hesseling AC, Savic RM. Garcia-Prats AJ, et al. Among authors: winckler j. PLoS Med. 2019 Apr 30;16(4):e1002789. doi: 10.1371/journal.pmed.1002789. eCollection 2019 Apr. PLoS Med. 2019. PMID: 31039153 Free PMC article.
100 results